Puration (PURA) Cannabis Extract Business Momentum Builds Supporting Potential Rapid PPS Increase From $0.03 To $1.00
August 05 2016 - 10:01AM
InvestorsHub NewsWire
Shareholder Base
Expands with 5 Million Shares Trading Volume in Past 20 Trading
Days
Stock Technical Analysis Indicates Very Bullish
Outlook
New York, NY -- August 5,
2016 -- Wall Street Corner Report continues to highlight Puration,
Inc. (PURA).
The Company up until July 8th, 2016 had only traded
500,000 over the previous 2 years. After recently announcing
their last year of work developing a highly refined cannabis
extraction process and their plans to begin generating a forecasted $3 million in revenue over the next 12
months, the market began to take some notice. Earlier this
week, Puration announced signing the
first of 3 anticipated $1 million contracts. In the last
20 trading days, the Company has traded over 5 million
shares. Yesterday, the Company traded almost a million shares
in a single day.
The online analysis
firm, Stock Technical
Analysis, indicates
that current candlestick analysis rates PURA’s potential as
very bullish.
Puration’s potential is still largely unrealized by the
market. As market exposure continues to improve and the
shareholder base continues to expand, Wall Street Corner Report
anticipates trading volume and PPS to increase substantially.
The Wall Street Corner
Report considers PURA an entrepreneurial and earlier
version of GW
Pharmaceuticals (GWPH). PURA is
comparable to GWPH in that both are
developing commercial applications of cannabis extract
process. Both companies are developing collaboration
agreements with other companies that will utilize their extracted
concentrates to infuse into existing product lines.
As PURA’s prospects becoming more
disseminated throughout the market, Wall Street
Corner Report anticipates a rapid PPS increase to as high as
$1.00.
GWPH has a market cap of $2B - approximately 33 times
revenue. The majority of revenue is non-cash consideration
while the company is still largely in a research phase.
If PURA were to achieve a valuation at
only 15 times its forecasted $3 million revenue, the PPS would be
$0.90.
To learn more about Puration:
www.purationinc.com
Follow Puration on Twitter:
https://twitter.com/Puration710
Visit Puration on
Facebook:
https://www.facebook.com/puration/
Wall Street Corner
Report is the
premier discovery site for promising, yet undiscovered small and
micro-cap stocks featuring opportunities in an ethical,
professional, and responsible manner. We're not fiendishly 'short'
sighted nor are we here to dream the impossibly 'long' dream.
We take a practical view on the big ideas of well-intentioned
management and look to profit on each reasonably achievable step
the well intentioned mangers take toward their big
ideas.
http://www.wallstreetcornerreport.com/
https://twitter.com/WallStCornerRpt
Safe Harbor Act: This release includes forward-looking statements
made pursuant to the safe harbor provisions of the Private
Securities Litigation Reform Act of 1995 that involves risks and
uncertainties including, but not limited to, the impact of
competitive products, the ability to meet customer demand, the
ability to manage growth, acquisitions of technology, equipment, or
human resources, the effect of economic business conditions and the
ability to attract and retain skilled personnel. The Company is not
obligated to revise or update any forward-looking statements in
order to reflect events or circumstances that may arise after the
date of this release.
Jack Taylor
info@wallstreetcornerreport.com
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Apr 2024 to May 2024
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about GW Pharmaceuticals PLC (NASDAQ): 0 recent articles
More GW Pharmaceuticals Plc ADS (MM) News Articles